PTX3 and chronic kidney disease: On the other hand, type 1 diabetic patients had an increased median SAT PTX3 mRNA level compared to type 2 diabetic and non-diabetic CKD patients (9.1 [0.7–49.3] vs. 3.7 [0.2–46.6] vs. 1.0 [0.2–70.3] RQ, p = 0.005), Figure 1E).